JRCT ID: jRCTb030230126
Registered date:08/06/2023
Cultured adipose-derived stem cells for breast reconstruction
Basic Information
Recruitment status | Complete |
---|---|
Health condition(s) or Problem(s) studied | Breast deformity after breast-conserving surgery followed by radiation therapy |
Date of first enrollment | 08/06/2023 |
Target sample size | 5 |
Countries of recruitment | Japan |
Study type | Interventional |
Intervention(s) | 1) Adipose tissue collection with inhalation technique 2) Administration of autologous adipose-derived stem cells and adipose tissue with cultured cells |
Outcome(s)
Primary Outcome | Number and Grade (CTCAR v5.0-JCOG) of adverse events related to this research from day 0 to 18 months follow-up |
---|---|
Secondary Outcome | - Comparison of affected and unaffected breasts in percent change of elasticity measured by ultrasonic elastography - Change in breast subcutaneous tissue thickness and breast volume measured by ultrasonography and breast MRI - Patient reported outcome on health related quality of life evaluated with Breast Q |
Key inclusion & exclusion criteria
Age minimum | >= 20age old |
---|---|
Age maximum | Not applicable |
Gender | Female |
Include criteria | Patients who meet all of the following conditions: 1) Female, age 20 years and older 2) Primary breast cancer in one side 3) Anticipate reconstruction for breast deformity after breast-conserving surgery followed by radiation therapy 4) Last surgery for breast cancer more than 1 year prior to enrollment 5) No metastasis, residual or local recurrence, and no evidence of recurrence of cancer 6) Available adipose tissue collection with inhalation technique 7) Signed written informed consent |
Exclude criteria | Patients who meet any of the following conditions: 1) Not enough adipose tissue collection 2) Not controlled infectious diseases 3) Evidence of infection in treatment target area and adipose tissue collection site 4) History of breast augmentation in affected side 5) Presence of any other known malignancy or metastasis 6) Use of anticancer, immunosuppressant, anticoagulant or antiplatelet agents during this research, from first adipose tissue collection to 18-month follow-up 7) Surgery or radiation therapy in treatment target area and adipose tissue collection site during this research, from first adipose tissue collection to 18-month follow-up 8) Considered by investigator due to any other severe condition such as cardiac, lung, liver, kidney, auto-immune, not-controlled diabetes, or drug allergy 9) Pregnant or breast-feeding 10) Smoker or unavailable to quit smoking during this research, from first adipose tissue collection to 18-month follow-up 11) Not appropriate or not consent obtained for general anesthesia 12) Lack of cooperation with the procedures designated for this research 13) Considered as inappropriate for this research for any reason by investigators |
Related Information
Primary Sponsor | Komuro Yuzou |
---|---|
Secondary Sponsor | |
Source(s) of Monetary Support |
Contact
Public contact | |
Name | Kiyoko Uno |
Address | 2-11-1 Kaga Itabashi-ku Tokyo 173-8606 Tokyo Japan 173-8606 |
Telephone | +81-3-3964-1211 |
kiyoko.uno@med.teikyo-u.ac.jp | |
Affiliation | Teikyo University School of Medicine |
Scientific contact | |
Name | Yuzou Komuro |
Address | 2-11-1 Kaga Itabashi-ku Tokyo 173-8606 Tokyo Japan 173-8606 |
Telephone | +81-3-3964-1211 |
ykomuro@med.teikyo-u.ac.jp | |
Affiliation | Teikyo University School of Medicine |